معرفی
Laura Richmond serves as a Lecturer in Therapeutic Science Research at the University of Glasgow, based at the Wolfson Wohl Cancer Research Centre in Glasgow, Scotland. Her institutional affiliation positions her within a leading biomedical research environment focused on translational science.
Her research spans molecular mechanisms in cancer biology and advanced gene-editing technologies, with particular emphasis on:
- CRISPR-Cas9 applications and limitations in genomic engineering
- Pseudokinase signaling pathways (especially TRIB proteins) in oncogenesis
- Molecular diagnostics for protein expression analysis
- Safety implications of gene editing in hematopoietic systems
Analysis of her publication trends reveals a consistent trajectory from foundational molecular physiology (2013 Drosophila studies) toward cutting-edge cancer-focused CRISPR applications (2020-2024), demonstrating evolving expertise at the intersection of gene editing and oncology. Her work increasingly addresses translational challenges in therapeutic development.
Based at the Wolfson Wohl Cancer Research Centre, she contributes to collaborative teams investigating molecular drivers of cancer and developing precision therapeutic approaches, with infrastructure supporting advanced genomic and proteomic analyses.
